The role of HER2 in canine mammary carcinoma is controversial; therefore, this study aimed to investigate the protein expression and cytogenetic alterations of HER2 and their correlation with the proliferative fraction, estrogen receptor, and other clinicopathological parameters in canine mammary carcinoma. The gene discussed is ERBB2; the disease is breast carcinoma.